Updated:
Fight Against Cancer Innovation Trust
FACIT commercializes world-class cancer innovation by seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
Fight Against Cancer Innovation Trust
FACIT commercializes world-class cancer innovation by seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy. It was established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. FACIT actively manages a diverse portfolio of Ontario oncology assets, including therapeutics, imaging, diagnostics, and technology platforms, spanning proof-of-concept to clinical development. Together with OICR, it works to attract more R&D investment in Ontario and help oncology innovations reach the market.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
MaRS Centre, 661 University Avenue, Suite 510, Toronto, Ontario, Canada M5G 0A3
Sector focus
Frequently asked questions
How does FACIT source its investment opportunities?
FACIT's deal flow originates primarily from the Ontario Institute for Cancer Research and affiliated academic and hospital research networks across Ontario. The firm's translational mandate gives it early access to oncology innovations before they become widely known to generalist investors. It also scouting programs and pitch competitions, such as Falcons' Fortunes, to identify emerging academic founders.
What is FACIT's relationship with the Ontario Institute for Cancer Research?
FACIT was established by the Ontario Institute for Cancer Research to serve as its commercialization and technology-transfer arm. While FACIT operates as an independent venture firm, it works closely with OICR's research pipeline and receives part of its funding through the Government of Ontario via OICR. This relationship ties FACIT's investment strategy to a provincial economic development mandate.
What types of cancer innovations does FACIT invest in?
FACIT invests across therapeutics, medical devices, and diagnostics — all focused on oncology. Its portfolio includes companies developing immunotherapies, targeted small molecules, surgical visualization technology, and molecular diagnostics. The unifying thread is an origin in Ontario research and a clear path to addressing unmet cancer patient needs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: